Roche Places Artificial Intelligence at Center of Drug Development Push
Swiss pharmaceutical giant Roche is intensifying its commitment to artificial intelligence as the company seeks to accelerate drug discovery, improve research efficiency, and strengthen a pipeline that executives believe could deliver a new generation of blockbuster medicines before the end of the decade. The strategy was presented during Roche’s investor-focused Pharma Day, where company leaders…